Genpact (NYSE:G) has been rated Neutral by JPMorgan Chase & Co.

JPMorgan Chase & Co. Raises Share Rating Genpact (NYSE:G – Free Report) from an underweight rating to a neutral rating in a research note issued on Wednesday morning, MarketBeat.com reports. JPMorgan Chase & Co. currently has a $40.00 price target on shares of the business services provider, down from the previous price target of $43.00.

Several other equities analysts have also recently commented on the company. Needham & Company LLC reiterated a buy rating and set a $40.00 price target on shares of Genpact in a research note on Friday, May 10. StockNews.com lowered Genpact from a strong buy to a buy in a research note on Friday, April 5. Wedbush reiterated a neutral rating and set a $35.00 price target on shares of Genpact in a research note on Friday, May 10. BMO Capital Markets lowered their price target on Genpact from $39.00 to $38.00 and set a “market perform” rating on the stock in a research note on Friday, May 10. Finally, Citigroup lowered their price target on Genpact from $36.00 to $33.00 and set a neutral rating on the stock in a research note on Monday, April 22. Six investment analysts have rated the stock a “hold” and two have given it a “buy” rating. Based on data from MarketBeat, the company has an average rating of “hold” and a consensus price target of $37.63.

Get our latest stock analysis on Genpact

Genpact Price Performance

Shares of NYSE:G opened at $34.01 on Wednesday. The company has a current ratio of 1.54, a current ratio of 1.54 and a debt-to-equity ratio of 0.36. The stock’s fifty day simple moving average is $32.62, and a two-hundred day simple moving average is $33.37. Genpact has a one-year low of $29.41 and a one-year high of $39.58. The stock has a market capitalization of $6.12 billion, a P/E ratio of 9.72, a price-to-earnings-growth ratio of 1.55 and a beta of 1.11.

Genpact (NYSE:G – Get Free Report) last released its financial results on Thursday, May 9. The business services provider reported $0.68 earnings per share for the quarter, topping analysts’ consensus estimates of $0.62 by $0.06. The company had revenue of $1.13 billion for the quarter, compared to analysts’ expectations of $1.11 billion. Genpact had a return on equity of 22.71% and a net margin of 14.21%. Analysts forecast Genpact to post earnings per share of $2.7 for the current fiscal year.

Genpact cuts dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 25. Shareholders of record on Wednesday, September 11 will receive a dividend of $0.1525 per share. This represents a $0.61 annualized dividend and a yield of 1.79%. The ex-dividend date is Wednesday, September 11. Genpact’s payout ratio is currently 17.43%.

Insider Buying and Selling at Genpact

In other Genpact news, Director N.V. Tyagarajan sold 1,000 shares of Genpact stock in a transaction dated Wednesday, June 5. The shares were sold at an average price of $33.17, for a total transaction value of $33,170.00. Following the completion of the transaction, the director now owns 7,300 shares of the company’s stock, valued at approximately $242,141. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link . Insiders own 2.80% of the company’s stock.

Institutional inflows and outflows

Several hedge funds and other institutional investors recently modified their holdings in G. EdgeRock Capital LLC bought a new position in shares of Genpact in the fourth quarter worth about $25,000. CWM LLC increased its holdings in shares of Genpact by 160.8% in the second quarter. CWM LLC now owns 952 shares of the business services provider’s stock worth $31,000 after purchasing an additional 587 shares in the last quarter. EverSource Wealth Advisors LLC increased its holdings in shares of Genpact by 106.3% in the fourth quarter. EverSource Wealth Advisors LLC now owns 914 shares of the business services provider’s stock worth $32,000 after purchasing an additional 471 shares in the last quarter. GAMMA Investing LLC bought a new position in shares of Genpact in the fourth quarter worth about $43,000. Finally, Massmutual Trust Co. FSB ADV increased its holdings in Genpact by 120.0% during the first quarter. Massmutual Trust Co. FSB ADV now owns 1,813 shares of the business services provider’s stock valued at $60,000 after purchasing an additional 989 shares during the last quarter. Hedge funds and other institutional investors own 96.03% of the company’s stock.

Genpact Company Profile

(Download the free report)

Genpact Limited offers business process outsourcing and IT services in India, the rest of Asia, North and Latin America, and Europe. It operates in three segments: Financial Services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail client onboarding, customer service, collections, card processing, loan and payment operations, commercial lending, equipment and auto lending, mortgage lending, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and risk assessment support, new business processing, policy administration, claims management, catastrophe modeling, and actuarial services, as well as property and casualty claims.

read more

Get Genpact news and reviews daily – Enter your email address below to receive a concise summary of the latest news and analyst ratings for Genpact and related companies in MarketBeat.com’s FREE daily newsletter.